Opportunity for reduced antibiotic use in acne treatment

June 30, 2014
Opportunity for reduced antibiotic use in acne treatment

(HealthDay)—Duration of antibiotic use for acne appears to be decreasing; however, nearly one-fifth of courses exceed six months, according to a study published in the July issue of the Journal of the American Academy of Dermatology.

Noting that recent guidelines suggest that oral for acne should be limited to three to six months, Young H. Lee, M.D., from the Penn State Milton S. Hershey Medical Center, and colleagues examined the duration of oral antibiotic therapy. Data for the were collected from the MarketScan Commercial Claims and Encounters database. The duration and costs of antibiotic therapy were determined using claims data.

The researchers found that 93 percent of courses were less than nine months, with the mean course duration 129 days. Overall, 57.8 percent of the 31,634 courses did not include concomitant topical retinoid therapy. The mean duration was 133 days with topical retinoid use and 127 days without topical retinoid use. For longer than six months, the mean excess direct cost was $580.99/person.

"Duration of antibiotic use is decreasing when compared with previous data. However, 5,547 (17.53 percent) courses exceeded six months, highlighting an opportunity for reduced antibiotic use," the authors write.

One author disclosed financial ties to Allergan, Galderma, Intrepid, and Stiefel/GSK.

Explore further: Treatment of acne using oral antibiotics associated with reporting symptoms of sore throat

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Docs decide on duration of antibiotics in long-term care

March 20, 2013

(HealthDay)—Prescriber preference rather than patient characteristics influences the duration of antibiotic courses in long-term care residents, according to research published online March 18 in JAMA Internal Medicine.

Quality improvement methods up appropriate antibiotic rx

April 15, 2013

(HealthDay)—Quality improvement (QI) methods can be used to rapidly implement national guidelines relating to appropriate first-line antibiotic therapy for children aged 3 months or older with community-acquired pneumonia ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.